Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-06

Clinical Trial Update: A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel [Phase 3]

View source ↗

Summary

A multicenter extension Phase 3 trial evaluated the safety of testosterone gel in adult male hypogonadism, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Testosterone gel (Testosterone)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Adult Male Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2017-10-06